1. miR-217 Is a Useful Diagnostic Biomarker and Regulates Human Podocyte Cells Apoptosis via Targeting TNFSF11 in Membranous Nephropathy
   Jing Li et al, 2017, BioMed Research International CrossRef
2. Gene expression network regulated by DNA methylation and microRNA during microcystin-leucine arginine induced malignant transformation in human hepatocyte L02 cells
   Hong-qiang Chen et al, 2018, Toxicology Letters CrossRef
3. MiR-130a-5p prevents angiotensin II-induced podocyte apoptosis by modulating M-type phospholipase A2 receptor
   Dongwei Liu et al, 2018, Cell Cycle CrossRef
4. Upregulated microRNAs in membranous glomerulonephropathy are associated with significant downregulation of IL6 and MYC mRNAs
   Cristina Barbagallo et al, 2019, Journal of Cellular Physiology CrossRef
5. MicroRNAs in Kidney Diseases
   Grazia Serino et al, 2016, Biomarkers in Kidney Disease CrossRef
6. Circ_0000524/miR‐500a‐5p/CXCL16 axis promotes podocyte apoptosis in membranous nephropathy
   Zhiqiang Sun et al, 2021, European Journal of Clinical Investigation CrossRef
7. MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
   Xiaoshan Zhou et al, 2022, Frontiers in Pharmacology CrossRef
8. Circulating miRNAs in extracellular vesicles related to treatment response in patients with idiopathic membranous nephropathy
   In O. Sun et al, 2022, Journal of Translational Medicine CrossRef
9. MicroRNAs in Kidney Diseases
   Grazia Serino et al, 2015, Biomarkers in Kidney Disease CrossRef
10. Next Generation Sequencing: A Tool for This Generation of Nephrologists
    Lea Landolt et al, 2016, European Medical Journal CrossRef
11. Biomarker Identification in Membranous Nephropathy Using a Long Non-coding RNA-Mediated Competitive Endogenous RNA Network
    Guangyu Zhou et al, 2021, Interdisciplinary Sciences: Computational Life Sciences CrossRef
12. Renal mitochondrial injury in the pathogenesis of CKD: mtDNA and mitomiRs
    Maria V. Irazabal et al, 2022, Clinical Science CrossRef
13. Altered expression of serum miR‐106a, miR‐19b, miR‐17, and PTEN in patients with idiopathic membranous nephropathy
    Lina Wu et al, 2021, Journal of Clinical Laboratory Analysis CrossRef
14. A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy
    Shiva Kalantari et al, 2017, Biomarkers in Medicine CrossRef
15. Novel Biomarkers in Membranous Nephropathy
    Qiuying Liu et al, 2022, Frontiers in Immunology CrossRef
16. MicroRNAs as Biomarkers for Nephrotic Syndrome
    Kenji Tsuji et al, 2020, International Journal of Molecular Sciences CrossRef
17. Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy
    Roza Motavalli et al, 2021, Cytokine CrossRef
18. Establishment of microRNA, transcript and protein regulatory networks in Alport syndrome induced pluripotent stem cells
    Wenbiao Chen et al, 2018, Molecular Medicine Reports CrossRef
19. MicroRNAs in chronic glomerulonephritis: Promising biomarkers for diagnosis and prognosis estimation
    E. S. Kamyshova et al, 2017, Terapevticheskii arkhiv CrossRef
20. Advances in the Research of Membranous Nephropathy
    惠紫 张, 2024, Advances in Clinical Medicine CrossRef
21. Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy
    Hua Miao et al, 2022, Frontiers in Pharmacology CrossRef
22. Roles of microRNAs in renal disorders related to primary podocyte dysfunction
    Rahim Iranzad et al, 2021, Life Sciences CrossRef
23. Identification of key pathways and genes in different types of chronic kidney disease based on WGCNA
    Yuhe Guo et al, 2019, Molecular Medicine Reports CrossRef
24. Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
    Feng Liu et al, 2022, Frontiers in Physiology CrossRef
25. Dicer and Drosha expression in patients with nephrotic syndrome
    Seyyedeh Mina Hejazian et al, 2020, BioFactors CrossRef